Cancer Screening Test Receipt — United States, 2018

Sabatino, Susan A.; Thompson, Trevor; White, Mary C.; Shapiro, Jean A.; Moor, Janet de; Doria–Rose, V. Paul; Clarke, Tainya C.; Richardson, Lisa C.

doi:10.15585/mmwr.mm7002a1

Cited by 95 publications

(96 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This paper extends the evidence about multi-level influences on cervical screening by linking PCP survey data to contemporaneous cervical cancer utilization data of their patients. Our work supports prior findings demonstrating that younger patients are less likely to be screened than older women and that Black women are more likely to be screened than White women, but contrary to prior work, shows that Hispanic and Asian women were more likely in this sample to be screened than White women ( Sabatino et al, 2021 , Watson et al, 2017 , Cervical Cancer Screening, 2020 ). We also found that patients of female PCPs were more likely to be up-to-date with cervical cancer screening than those of male PCPs.…”

Section: Discussionsupporting

confidence: 83%

“…Conceptual models suggest that variation in use of cancer screening occurs at multiple levels including patient, provider, and clinic ( Zapka et al, 2003 , Beaber et al, 2015 ). Yet, most literature on screening variation has focused on patient characteristics, and has found greater use among women who are Black vs. White, White vs. Asian, Hispanic, insured (vs. uninsured), or of higher (vs. lower) socioeconomic status ( Sabatino et al, 2021 , Watson et al, 2017 , Cervical Cancer Screening, 2020 ).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Patient, provider, and clinic factors associated with the use of cervical cancer screening

Haas

Vogeli

et al. 2021

Preventive Medicine Reports

View full text Add to dashboard Cite

Cervical cancer screening delivery remains suboptimal. Understanding the multiple influences on use of screening is important to designing interventions. We describe the influence of patient, primary care provider (PCP), and clinic characteristics on whether a woman is up-to-date with cervical screening as of December 2016. PCPs (n = 194) and their female screen-eligible patients age 21–65 years (n = 32,115) were included in this cross-sectional analysis of patients from two primary care networks linked to a contemporaneous PCP survey. Principal independent variables for patients included : age, race, insurance, continuity of care; for PCP included : overall satisfaction with the practice of medicine, gender, hours worked per week, financial support for achieving clinical targets; and for clinic included : routine receipt of data on preventive care performance and language translation resources. Overall, 66.6% of women were up-to-date. Women were less likely to be up-to-date with cervical cancer screening if they were younger and were more likely to be screened if they were Black, Hispanic or Asian vs. White. Women with greater continuity of primary care or with a female PCP were more likely to be up-to-date (1.52; 1.33–1.75); those who received care in a clinic that was less prepared to manage language translation were less likely to be up-to-date (0.78; 0.65–0.95). Patient, provider, and clinic factors all influence use of cervical cancer screening. Systems interventions like improving continuity of care, promoting translation services, or enhanced efforts to track screening among patients of male PCPs may improve delivery.

show abstract

Section: Discussionsupporting

confidence: 83%

Section: Introductionmentioning

confidence: 99%

Patient, provider, and clinic factors associated with the use of cervical cancer screening

Haas

Vogeli

et al. 2021

Preventive Medicine Reports

View full text Add to dashboard Cite

show abstract

“…During the height of service disruptions, 77% and 90% of clinics stopped offering breast and cervical cancer screenings, respectively, and half discontinued colorectal cancer screening. This is particularly concerning as the majority of eligible patients were not up to date on screening at baseline, and screening participation was well below national averages ( Sabatino et al, 2021 ). Although cancer services have largely resumed, heightened clinic hygiene protocols and physical distancing requirements limit the numbers of in-person visits that can be offered each day ( Centers for Disease Control, 2020 ).…”

Section: Discussionmentioning

confidence: 99%

Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in “Back on track with screening” quality improvement projects

Fisher‐Borne

Isher-Witt

Comstock

et al. 2021

Preventive Medicine

View full text Add to dashboard Cite

The COVID-19 pandemic has contributed to decreases in breast, colorectal, and cervical cancer screenings between 86 and 94% compared to three-year averages. These postponed screenings have created backlogs that systems will need to address as healthcare facilities re-open for preventive care. The American Cancer Society is leading a 17-month intervention with 22 federally qualified health centers (FQHCs) across the United States aimed at reducing cancer incidence and mortality disparities and alleviating additional strain caused by COVID-19. This study describes COVID-related cancer screening service disruptions reported by participating FQHCs. Selected FQHCs experienced service disruptions and/or preventive care cancellations due to COVID-19 that varied in severity and duration. Fifty-nine percent stopped cancer screenings completely. Centers transitioned to telehealth visits or rescheduled for the future, but the impact of these strategies may be limited by continued pandemic-related disruptions and the inability to do most screenings at home; colon cancer screening being the exception. Most centers have resumed in-person screening, but limited in person appointments and high levels of community transmission may reduce FQHC abilities to provide catch-up services. FQHCs provide critical cancer prevention services to vulnerable populations. The delivery of culturally competent, high-quality healthcare can mitigate and potentially reverse racial and ethnic disparities in cancer prevention testing and treatment. Ensuring and expanding access to care as we move out of the pandemic will be critical to preventing excess cancer incidence and mortality in vulnerable populations.

show abstract

“… 1 , 2 However, a sharp decline in cervical cancer screening rates among young women has occurred in recent years. 3 Unvaccinated women who have not had a screening may remain susceptible to cervical cancer. Herein, we examined cervical cancer screening uptake and adherence among women in the US in 2019 stratified by HPV vaccination status.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Cervical Cancer Screening Uptake and Adherence Among Women Without Human Papillomavirus Vaccination in the US

et al. 2021

View full text Add to dashboard Cite

show abstract

Cancer Screening Test Receipt — United States, 2018

Cited by 95 publications

References 6 publications

Patient, provider, and clinic factors associated with the use of cervical cancer screening

Patient, provider, and clinic factors associated with the use of cervical cancer screening

Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in “Back on track with screening” quality improvement projects

Evaluation of Cervical Cancer Screening Uptake and Adherence Among Women Without Human Papillomavirus Vaccination in the US

Contact Info

Product

Resources

About